Stefan James

Uppsala University

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Elmir Omerovic

Karolinska University Hospital

SWEDEN

View details

Sunil V. Rao

UNITED STATES

View details

Magnus Settergren

Associate Professor

Karolinska Institutet

SWEDEN

View details

Kai Eggers

Uppsala University

SWEDEN

View details

Sergey Rodin

Uppsala University

SWEDEN

View details

Tomas Jernberg

Karolinska Institutet

SWEDEN

View details

David Erlinge

Lund University

SWEDEN

View details

Jonathan Tjerkaski

Karolinska Institutet

SWEDEN

View details

Ramzi Ajjan

Associate Professor/Consultant

University of Leeds

UNITED KINGDOM

View details

Sacharias von Koch

Lund University

SWEDEN

View details

Naishu Kui

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Azfar Ghaus Zaman

Clinical Professor of Cardiology

Frimley Health NHS Foundation Trust

UNITED KINGDOM

View details

Peter Jüni

Professor of Medicine and Clinical Trials

University of Oxford

UNITED KINGDOM

View details

Xavier Rossello

Fundació Institut d'Investigació Sanitària Illes Balears

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stefan James

Research Interests

Explore related searches

Contact this professor

Articles (21)

Mortality and morbidity after transcatheter aortic valve implantation compared to an age- and sex-matched control population: a population-based study from the SWEDEHEART registry

Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trial

EuroHeart: improving cardiovascular care through data collection and international collaboration

Long-Term Outcome of Percutaneous Coronary Intervention Using Absorb Bioresorbable Scaffold: A SCAAR Study

Recommended methodologies for clinical investigations of high-risk medical devices—Conclusions from the European Union CORE–MD Project

Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA‐MI Trial

Balloon‐Expandable Versus Self‐Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry

Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months

2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention

The ESC Scientific Documents Committee: purposes and achievements

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk

Regional assessment of availability for transcatheter aortic valve implantation in Sweden: a long-term observational study

Is the TIME study on antihypertensive therapy and chronotropic effects on cardiovascular outcomes a pragmatic trial?

Patients With Bicuspid Aortic Stenosis Demonstrate Adverse Left Ventricular Remodeling and Impaired Cardiac Function Before Surgery With Increased Risk of Postoperative Heart Failure

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack

Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI

Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial

Myocardial infarction after elective percutaneous coronary intervention—which cardiac troponin cut-off to use?

Bleeding avoidance strategies in percutaneous coronary intervention

Collaborators (14)

Elmir Omerovic

Sunil V. Rao

Magnus Settergren

Kai Eggers

Sergey Rodin

Tomas Jernberg

David Erlinge

Jonathan Tjerkaski

Ramzi Ajjan

Sacharias von Koch

Naishu Kui

Azfar Ghaus Zaman

Peter Jüni

Xavier Rossello

Make your next move.